Skip to main content
رجوع
ALMS logo

Alumis Inc. Common Stock

جودة البيانات: 100%
ALMS
NASDAQ Healthcare Biotechnology
KWD 24.81
▲ KWD 1.74 (7.54%)
القيمة السوقية: 2.92B
نطاق اليوم
KWD 23.44 KWD 24.94
نطاق 52 أسبوعًا
KWD 2.76 KWD 30.60
حجم التداول
1,843,898
متوسط 50 يوم / 200 يوم
KWD 26.18 / KWD 10.64
الإغلاق السابق
KWD 23.07

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -12.0 0.3
P/B 9.7 3.0
ROE % -86.7 3.7
Net Margin % -1011.8 3.8
Rev Growth 5Y % 10.0
D/E 0.1 0.2

السعر المستهدف للمحللين

Hold
KWD 38.44 +54.9%
Low: KWD 32.00 High: KWD 50.00
ربحية السهم المستقبلية
-KWD 2.95
الإيرادات المقدّرة
7.89M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.93
KWD 0.44 – KWD 1.39
840.35M 2
FY2029 -KWD 0.96
-KWD 1.44 – -KWD 0.46
422.24M 4
FY2028 -KWD 2.01
-KWD 2.80 – -KWD 1.04
172.50M 6

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-19 -KWD 0.92 -KWD 0.95 -3.0%
2025-11-13 -KWD 0.92 -KWD 1.06 -15.2%
2025-08-13 -KWD 1.11 -KWD 1.17 -5.4%
2025-05-14 -KWD 1.47 -KWD 1.82 -23.8%
2025-03-19 -KWD 1.40 -KWD 0.23 +83.6%
2024-11-13 -KWD 1.64 -KWD 1.73 -5.5%
2024-08-13 -KWD 4.50 -KWD 23.10 -413.3%
2024-03-31 N/A -KWD 0.96

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Debt/Equity of 0.12 — conservative balance sheet
Negative free cash flow of -370.18M
PEG of 0.47 suggests growth is underpriced
Capital efficient — spends only 2.72% of revenue on capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-86.69%
ROIC-94.73%
Net Margin-1011.75%
Op. Margin-1776.32%

الأمان

Debt / Equity
0.12
Current Ratio4.34
Interest Coverage0.00

التقييم

P/E Ratio
-11.98
Forward P/EN/A
P/B Ratio9.68
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 24.05M Net Income (TTM) -243.33M
ROE -86.69% ROA -59.07%
Gross Margin 85.46% Operating Margin -1776.32%
Net Margin -1011.75% Free Cash Flow (TTM) -370.18M
ROIC -94.73% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.12 Current Ratio 4.34
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -11.98 Forward P/E N/A
P/B Ratio 9.68 P/S Ratio 121.22
PEG Ratio 0.47 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA 725.47
Forward P/S 369.42 Fwd Earnings Yield N/A
FCF Yield -12.70%
Market Cap 2.92B Enterprise Value 2.86B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 24.05M 0.0 0.0 0.0
Net Income -243.33M -294.23M -154.99M -111.93M
EPS (Diluted) -2.86 -10.38 -2.99 -14.93
Gross Profit 20.55M -3.15M 0.0 -250,000.0
Operating Income -427.20M -300.75M -158.17M -113.85M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 411.94M 340.99M 89.61M 108.17M
Total Liabilities 110.64M 80.89M 428.87M 303.41M
Shareholders' Equity 301.30M 260.10M -339.26M -195.24M
Total Debt 36.91M 30.72M 32.58M 1.78M
Cash & Equivalents 89.67M 169.53M 46.00M 25.61M
Current Assets 318.23M 306.19M 53.36M 102.56M
Current Liabilities 73.32M 50.91M 20.87M 13.35M